AGENDA
CELLULAR AND MOLECULAR BIOLOGY AREA
CONFERENCE ON GENETIC AND EPIGENETIC ASPECTS OF CANCER
Honolulu, Hawaii, January 19 to January 21, 1981
| Monday, January 19, 1981 |
||
| WELCOMING REMARKS | Yoji Ikawa Michael Gottesman |
|
| 9:00-12:00am | SESSION I - Chairman: Michael Gottesman | |
| Induction of Heritable Tumors in Mice: Problems of Exposure of Germ Cells to Carcinogenic Agents | Taisei Momura | |
| Isolation of a Rat Substrain with High Incidence of Colon Carcinoma | Makoto Miyamoto | |
| Enhancement or Suppression of Cancer Occurrence in F1 Hybrids of Different Mouse Strains | Kazuo Moriwaki | |
| 1:00- 8:00pm | Lunch, Dinner, Free Discussion | |
| 8:00-11:00 pm | SESSION II - Chairman: Karen Beemon | |
| Stability and Fixation of Differentiation of Vertebrate Tissue Cells In Vivo and In Vitro | Goro Eguchi | |
| Full-term Development After Transplantation of Embryonic Nuclei into Enucleated Mouse Eggs | Peter Hoppe | |
| Regulation of Expression of SV40 T Antigen in Stem Versus Differentiated Cells | Carlo Croce | |
| Tuesday, January 20, 1981 | ||
| 8:30am-1:30pm | SESSION III - Chairmen: Geoffrey Cooper Harold Varmus | |
| Perturbed Epithelial-Mesenchynal Interaction Causes Accelerated Cancer Development in Mouse Mammary Glands | Teruyo Sakakura | |
| Mouse Lymphoid Leukemias are Symbiotic Complexes of Neoplastic Lymphocytes and their Microenvironments | Hiroshi Hirai | |
| A Genetic System for Studying Host Factors Involved in Transformation by Rous Sarcoma Virus | Michael Gottesman | |
| Search for Specific Erythroblastosis- Inducing Genes of Friend Leukemia Virus Complex and for their Target Cells | Yoji Ikawa | |
| Tyrosine Phosphorylation: A Mechanism of Transformation Shared by Four Classes of Retroviruses Having Structurally Unrelated Transforming Proteins | Karen Beemon | |
| Wednesday, January 21, 1981 | ||
| 8:30am-12:30pm | SESSION IV - Chairman: Yoji Ikawa | |
| Activation of the Transforming Potential of a Normal Cell Sequence | George Vande Woude | |
| On the Nature of Mutations Which Determine the Phenotype of Cells Infected with RNA Tumor Viruses | Harold Varmus | |
| Molecular Evidence for Mutation in Chemically Transformed Human Fibroblasts | Takeo Kakunaga | |
| Transfection by Cellular Transforming Genes | Geoffrey Cooper | |
| SUMMARY and CONCLUDING REMARKS | Michael Gottesman | |
| 12:30- 4:00pm | LUNCH and DISCUSSION | |
PARTICIPANTS
JAPAN
Dr. Goro Eguchi
Institute of Molecular Biology Faculty of Science Nagoya University Nagoya 464, Japan
Dr. Hiroshi Hirai
Laboratory of Experimental Pathology Aichi Cancer Center Research Institute Nagoya 464, Japan
Dr. Yoji Ikawa
Department of Viral Oncology Cancer Institute Kami-Ikebukuro, Toshima-ku Tokyo 170, Japan
Dr. Makoto Miyamoto
Department of Pathology Osaka University Medical School 4-3-57 Nakanoshima, Kita-ku Osaka 553, Japan
Dr. Kazuo Moriwaki
Department of Cytogenetics National Institute of Genetics Mishima Shizuoka-ken 411, Japan
Dr. Taisei Nomura
Department of Fundamental Radiology Osaka University Medical School Osaka 553, Japan
Dr. Teruyo Sakakura
Department of Experimental Pathology Aichi Cancer Center Research Institute Nagoya 464, Japan
UNITED STATES
Dr. Karen Beemon
Department of Tumor Virology The Salk Institute San Diego, California 92112
Dr. Geoffrey Cooper
Harvard University School of Medicine Department of Pathology Sidney Farber Cancer Institute Boston, Massachusetts
Dr. Carlo Croce
The Wistar Institute 36th Street and Spruce Philadelphia, Pennsylvania 19104
Dr. Michael Gottesman
Building 37, Room 2E22, DCBD Laboratory of Molecular Biology National Cancer Institute Bethesda, Maryland 20205
Dr. Peter Hoppe
The Jackson Laboratory Bar Harbor, Maine 04609
Dr. Takeo Kakunaga
Building 37, Room 3E08, DCCP Laboratory of Molecular Carcinogenesis National Cancer Institute Bethesda, Maryland 20205
Dr. Harold E. Varmus
Department of Microbiology University of California School of Medicine San Francisco, California 94143
Dr. George F. Vande Woude, Jr.
Building 41, Suite 100 Virus Tumor Biochemistry Section Laboratory of Molecular Virology National Cancer Institute Bethesda, Maryland 20205